Ardent Health Partners, Inc. (ARDT) - Q2 2024 10-Q Summary
Business Context and Reporting Period
This report covers the quarterly period ended June 30, 2024. Ardent Health Partners, Inc. operates 30 acute care hospitals across six states (Texas, Oklahoma, New Mexico, New Jersey, Idaho, and Kansas). The company recently completed an Initial Public Offering (IPO) on July 19, 2024, and converted from a limited liability company to a Delaware corporation on July 17, 2024. The financial statements reflect these changes retrospectively.
Key Financial Metrics
| Metric | Q2 2024 (3 Months) | Q2 2023 (3 Months) | YTD 2024 (6 Months) | YTD 2023 (6 Months) |
|---|---|---|---|---|
| Total Revenue | $1,470.9 million | $1,368.7 million | $2,909.9 million | $2,685.7 million |
| Net Income (GAAP) | $66.9 million | $55.7 million | $112.8 million | $79.5 million |
| Net Income Attributable to Ardent | $42.8 million | $33.1 million | $69.8 million | $37.2 million |
| Diluted EPS | $0.34 | $0.26 | $0.55 | $0.30 |
| Adjusted EBITDA | $122.3 million | $101.9 million | $218.1 million | $171.6 million |
| Operating Cash Flow (YTD) | $105.7 million (vs. $65.5 million YTD 2023) | |||
| Cash and Equivalents | $334.5 million (as of June 30, 2024) | |||
| Total Debt (Gross) | $1.09 billion (as of June 30, 2024) |
Material Changes vs. Prior Period
- Revenue Growth: Total revenue increased 7.5% in Q2 and 8.3% YTD compared to the prior year. This was driven by a 3.4% increase in adjusted admissions and a 4.1% increase in net patient service revenue per adjusted admission.
- Volume Trends: Inpatient admissions grew 5.1% in Q2, while outpatient surgeries decreased 2.8% due to strategic reallocation of resources away from high-volume, low-margin procedures (e.g., dental, ophthalmology).
- Expense Management: Salaries and benefits decreased as a percentage of revenue (42.4% in Q2 2024 vs. 43.7% in Q2 2023), primarily due to a $7.5 million reduction in contract labor expenses. Professional fees increased as a percentage of revenue due to higher costs for hospital-based providers and revenue cycle management services.
- Debt Reduction: On June 26, 2024, the company prepaid $100.0 million of its Term Loan B Facility and incurred a $1.9 million loss on debt extinguishment. The ABL Credit Agreement was amended to increase capacity to $325.0 million and extend maturity to 2029.
- Government Stimulus: The company recognized $0 in government stimulus income in 2024, compared to $8.3 million in Q2 2023.
Outlook, Risks, and Unusual Items
- Cybersecurity Incident: A November 2023 ransomware attack caused an estimated $74 million pre-tax impact in 2023. While operations are no longer materially disrupted, billing delays persisted into Q1 2024. A consolidated class action lawsuit regarding the incident reached an agreement in principle in July 2024; the settlement is not expected to be material.
- Regulatory Updates: New directed payment programs in Oklahoma (effective April 2024) and New Mexico (pending CMS approval) are expected to provide a net benefit in excess of $150 million on an annualized basis.
- Liquidity: As of June 30, 2024, available liquidity was $623.6 million, comprising cash and $289.1 million in available ABL capacity. The net leverage ratio was 2.3x.
- Risks: Key risks include labor shortages, inflationary pressures on wages and supplies, changes in government reimbursement rates (Medicare/Medicaid), and the impact of the No Surprises Act.
Investor Verification Checklist
- IPO Proceeds: Verify the deployment of approximately $208.6 million in net IPO proceeds (including option exercise) and confirm the use of funds aligns with the Final Prospectus.
- Cybersecurity Costs: Monitor the final settlement amount of the class action lawsuit and the extent to which insurance offsets remaining remediation and legal costs.
- Regulatory Approvals: Track the status of the New Mexico Healthcare Delivery and Access Act (HDA Act) approval by CMS to confirm the projected $150 million+ annualized benefit.
- Contract Labor: Assess the sustainability of the reduction in contract labor expenses and the potential impact of future wage inflation on margins.
- Debt Covenants: Review compliance with the Ventas Master Lease covenants (minimum portfolio coverage ratio of 2.2x) and ABL fixed charge coverage ratios.